Product NDC: | 60760-007 |
Proprietary Name: | DOXAZOSIN |
Non Proprietary Name: | DOXAZOSIN MESYLATE |
Active Ingredient(s): | 4 mg/1 & nbsp; DOXAZOSIN MESYLATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60760-007 |
Labeler Name: | St Marys Medical Park Pharmacy |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075536 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130502 |
Package NDC: | 60760-007-30 |
Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (60760-007-30) |
NDC Code | 60760-007-30 |
Proprietary Name | DOXAZOSIN |
Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (60760-007-30) |
Product NDC | 60760-007 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DOXAZOSIN MESYLATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130502 |
Marketing Category Name | ANDA |
Labeler Name | St Marys Medical Park Pharmacy |
Substance Name | DOXAZOSIN MESYLATE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |